Holen Sie sich die Stockscreener-App
2.12
0.95%
0.02
Handel nachbörslich:
2.16
0.04
+1.89%
Schlusskurs vom Vortag:
$2.10
Offen:
$2.1
24-Stunden-Volumen:
52,897
Relative Volume:
0.75
Marktkapitalisierung:
$86.59M
Einnahmen:
$2.70M
Nettoeinkommen (Verlust:
$5.53M
KGV:
19.27
EPS:
0.11
Netto-Cashflow:
$-10.55M
1W Leistung:
+1.68%
1M Leistung:
-0.70%
6M Leistung:
-13.47%
1J Leistung:
-10.17%
1-Tages-Spanne:
$2.0901
$2.143
1-Wochen-Bereich:
$2.06
$2.143
52-Wochen-Spanne:
$1.82
$3.09
Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile
Firmenname
Oramed Pharmaceuticals Inc
Sektor
Branche
Telefon
646-844-1164
Adresse
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Vergleichen Sie ORMP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORMP
Oramed Pharmaceuticals Inc
|
2.12 | 85.77M | 2.70M | 5.53M | -10.55M | 0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-12 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2022-02-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-04-20 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-02-09 | Eingeleitet | National Securities | Buy |
| 2020-12-03 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-03-11 | Eingeleitet | Aegis Capital | Buy |
| 2019-09-11 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-12-11 | Fortgesetzt | B. Riley FBR, Inc. | Buy |
| 2016-05-26 | Bestätigt | FBR Capital | Outperform |
| 2015-12-01 | Bestätigt | H.C. Wainwright | Buy |
| 2015-11-19 | Eingeleitet | FBR Capital | Outperform |
| 2015-04-13 | Fortgesetzt | MLV & Co | Buy |
| 2014-01-30 | Bestätigt | Aegis Capital | Buy |
| 2014-01-08 | Bestätigt | Aegis Capital | Buy |
| 2014-01-08 | Eingeleitet | MLV & Co | Buy |
| 2013-12-03 | Eingeleitet | Aegis Capital | Buy |
Alle ansehen
Oramed Pharmaceuticals Inc Aktie (ORMP) Neueste Nachrichten
Can machine learning forecast Oramed Pharmaceuticals Inc. recoveryEarnings Summary Report & Real-Time Buy Signal Alerts - Newser
Published on: 2025-08-13 07:04:19 - Newser
Is Oramed Pharmaceuticals Inc. forming a reversal patternJuly 2025 Levels & Verified Swing Trading Watchlist - Newser
Can volume confirm reversal in Oramed Pharmaceuticals Inc.2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser
Detecting price anomalies in Oramed Pharmaceuticals Inc. with AIEarnings Summary Report & Real-Time Buy Signal Alerts - Newser
How high can Oramed Pharmaceuticals Inc. stock goFree Watchlist for Low Risk High Return - Newser
How Oramed Pharmaceuticals Inc. stock performs during market volatilityFree Daily Chart Pattern Stock Forecast - Newser
Is now a turning point for Oramed Pharmaceuticals Inc.AI Volatility Forecast and Risk Monitor - Newser
Alpha Tau Secures FDA Approval for Breakthrough Brain Cancer Treatment Trial, Raises $36.9M - Stock Titan
What to expect from Oramed Pharmaceuticals Inc. in the next 30 daysFree Stock Market Entry Timing Signals - Newser
Risk vs reward if holding onto Oramed Pharmaceuticals Inc.Daily Technical Chart Pattern Analysis Report - Newser
Can you recover from losses in Oramed Pharmaceuticals Inc.Free Short Term High Yield Stock Tips - Newser
Oramed Pharmaceuticals Inc. Stock Support and Resistance Levels You Should KnowShort-Term Growth Watch with Signal Prediction - Newser
Published on: 2025-08-10 20:12:47 - Newser
Can a trend reversal in Oramed Pharmaceuticals Inc. lead to recoveryFree Risk Adjusted Technical Entry Plan - Newser
Intraday pattern recognizer results for Oramed Pharmaceuticals Inc.Daily Exit and Entry Price Prediction - Newser
Diabetic Ketacidosis Treatment Market Set to Witness - openPR.com
What makes Oramed Pharmaceuticals Inc. stock price move sharplyMulti-Year Investment Performance Summary Report - Newser
What candlestick patterns are forming on Oramed Pharmaceuticals Inc.Daily Market Entry Strategy with Tools - Newser
Published on: 2025-08-05 21:05:42 - Newser
Recovery Signals Appearing in Oramed Pharmaceuticals Inc. ChartsReal Trader Watchlist of Hot Stocks Released - beatles.ru
How does Oramed Pharmaceuticals Inc. generate profit in a changing economyIdentify winners with top-tier analysis - Jammu Links News
What are analysts’ price targets for Oramed Pharmaceuticals Inc. in the next 12 monthsBuild wealth steadily with expert advice - Jammu Links News
How does Oramed Pharmaceuticals Inc. compare to its industry peersTriple-digit wealth increases - Jammu Links News
Should I hold or sell Oramed Pharmaceuticals Inc. stock in 2025Maximize gains with expert analysis - Jammu Links News
Is it the right time to buy Oramed Pharmaceuticals Inc. stockFree Market Dynamics Reports - Jammu Links News
Oramed Pharmaceuticals Inc. Stock Analysis and ForecastDiscover high-impact stocks for your portfolio - Jammu Links News
What is the dividend policy of Oramed Pharmaceuticals Inc. stockTap into rapid wealth building techniques - Jammu Links News
What are the latest earnings results for Oramed Pharmaceuticals Inc.Value Investing Review From AI Tools - Jammu Links News
Is Oramed Pharmaceuticals Inc. stock overvalued or undervaluedAI Powered Ideas With High Returns - Jammu Links News
Diabetes Pipeline 2025: Therapies Under Investigation, - openPR.com
Key External Factors That Drive Oramed Pharmaceuticals Inc. Stock Price MovementsConsistent Return Setup with Exit Strategy - Newser
How high can Oramed Pharmaceuticals Inc. stock price go in 2025Trend Following Ideas with Volume Confirmation - Newser
What are the technical indicators suggesting about Oramed Pharmaceuticals Inc.Advanced Screener Entry Points For Consistent Profits - Jammu Links News
Published on: 2025-07-30 11:09:17 - metal.it
Published on: 2025-07-29 17:32:00 - metal.it
Finanzdaten der Oramed Pharmaceuticals Inc-Aktie (ORMP)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):